[go: up one dir, main page]

SI0656014T1 - Protein Rib, celični površinski protein, ki posreduje imunost proti mnogim sevom streptokokov skupine B; postopek za čiščenje proteina, reagenčni komplet in farmacevtski sestavek - Google Patents

Protein Rib, celični površinski protein, ki posreduje imunost proti mnogim sevom streptokokov skupine B; postopek za čiščenje proteina, reagenčni komplet in farmacevtski sestavek

Info

Publication number
SI0656014T1
SI0656014T1 SI9430453T SI9430453T SI0656014T1 SI 0656014 T1 SI0656014 T1 SI 0656014T1 SI 9430453 T SI9430453 T SI 9430453T SI 9430453 T SI9430453 T SI 9430453T SI 0656014 T1 SI0656014 T1 SI 0656014T1
Authority
SI
Slovenia
Prior art keywords
protein
purification
pharmaceutical composition
reagent kit
streptococcus
Prior art date
Application number
SI9430453T
Other languages
English (en)
Inventor
Gunnar Lindahl
Margaretha Stalhammar-Carlemalm
Lars Stenberg
Original Assignee
Gunnar Lindahl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gunnar Lindahl filed Critical Gunnar Lindahl
Publication of SI0656014T1 publication Critical patent/SI0656014T1/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SI9430453T 1993-03-19 1994-03-21 Protein Rib, celični površinski protein, ki posreduje imunost proti mnogim sevom streptokokov skupine B; postopek za čiščenje proteina, reagenčni komplet in farmacevtski sestavek SI0656014T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9300234 1993-03-19
EP94911348A EP0656014B1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
PCT/SE1994/000246 WO1994021685A1 (en) 1993-03-19 1994-03-21 Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition

Publications (1)

Publication Number Publication Date
SI0656014T1 true SI0656014T1 (sl) 2003-12-31

Family

ID=20388669

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9430453T SI0656014T1 (sl) 1993-03-19 1994-03-21 Protein Rib, celični površinski protein, ki posreduje imunost proti mnogim sevom streptokokov skupine B; postopek za čiščenje proteina, reagenčni komplet in farmacevtski sestavek

Country Status (17)

Country Link
US (1) US5869064A (sl)
EP (1) EP0656014B1 (sl)
JP (1) JP3976334B2 (sl)
KR (1) KR100331358B1 (sl)
CN (1) CN1046291C (sl)
AT (1) ATE240351T1 (sl)
CA (1) CA2158658A1 (sl)
DE (1) DE69432658T2 (sl)
DK (1) DK0656014T3 (sl)
ES (1) ES2194024T3 (sl)
HU (1) HU217582B (sl)
NZ (1) NZ263275A (sl)
PT (1) PT656014E (sl)
SG (1) SG47049A1 (sl)
SI (1) SI0656014T1 (sl)
WO (1) WO1994021685A1 (sl)
ZA (1) ZA941958B (sl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
ID27482A (id) 1998-02-20 2001-04-12 Iaf Biochem Int Antigen streptococcus kelompok b
KR100790653B1 (ko) * 1998-12-22 2007-12-31 마이크로싸이언스 리미티드 유전자와 단백질들, 및 그들의 사용
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
AP2006003504A0 (en) * 1998-12-22 2006-02-28 Microscience Ltd Outer surface proteins, their genes, and their use.
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
NZ512574A (en) * 1998-12-23 2004-03-26 Iaf Biochem Int Novel streptococcus antigens useful as vaccines
GB9910375D0 (en) 1999-05-05 1999-06-30 Lindahl Gunnar Vaccine composition
CA2447775A1 (en) * 2001-05-31 2002-12-19 Fuso Pharmaceutical Industries, Ltd. Process for evaluating phagocytotic function and use thereof
JP3934605B2 (ja) * 2001-05-31 2007-06-20 扶桑薬品工業株式会社 感染症原因微生物の検出および同定のための改良された方法
WO2003068813A2 (en) * 2002-02-11 2003-08-21 Shire Biochem Inc Group b streptococcus antigen
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
RU2487890C2 (ru) * 2007-04-16 2013-07-20 МинерваКС Апс Слитый белок, способный индуцировать защитный иммунитет против стрептококка группы в, и вакцина, содержащая такой белок
RU2757426C2 (ru) 2015-10-21 2021-10-15 МинерваКС Апс Иммунногенный слитый белок
CA3004631A1 (en) 2015-12-30 2017-07-06 Minervax Aps Immunogenic complex for eliciting protective immunity against group b streptococcus
WO2018229708A1 (en) 2017-06-16 2018-12-20 Glaxosmithkline Biologicals Sa Method of treatment
WO2021099982A1 (en) 2019-11-22 2021-05-27 Glaxosmithkline Biologicals Sa Dosage and administration of a bacterial saccharide glycoconjugate vaccine
EP4066854A1 (en) 2021-03-29 2022-10-05 MinervaX Immunogenic fusion protein

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302386A (en) * 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
EP0367890A1 (en) * 1988-11-11 1990-05-16 HighTech Receptor AB Protein Arp, with immunoglobulin A binding activity, cloning and expression thereof
IL95578A (en) * 1989-09-15 1998-08-16 Gen Hospital Corp Conjugate vaccine formed from a polysaccharide and a c protein of b-streptococcus
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
WO1992017588A2 (en) * 1991-03-29 1992-10-15 Ervin Faulmann METHOD FOR PRODUCTION OF AN IgA BINDING PROTEIN DERIVED FROM GROUP B STREPTOCOCCI

Also Published As

Publication number Publication date
AU681130B2 (en) 1997-08-21
US5869064A (en) 1999-02-09
WO1994021685A1 (en) 1994-09-29
JP3976334B2 (ja) 2007-09-19
SG47049A1 (en) 1998-03-20
DE69432658D1 (de) 2003-06-18
HUT72841A (en) 1996-05-28
AU6389194A (en) 1994-10-11
ZA941958B (en) 1995-01-27
EP0656014A1 (en) 1995-06-07
ES2194024T3 (es) 2003-11-16
ATE240351T1 (de) 2003-05-15
CN1046291C (zh) 1999-11-10
DE69432658T2 (de) 2004-04-08
EP0656014B1 (en) 2003-05-14
CN1119442A (zh) 1996-03-27
CA2158658A1 (en) 1994-09-29
NZ263275A (en) 1997-07-27
HU217582B (hu) 2000-02-28
JPH09500092A (ja) 1997-01-07
HK1008825A1 (en) 1999-05-21
PT656014E (pt) 2003-09-30
KR100331358B1 (ko) 2002-08-13
KR960701096A (ko) 1996-02-24
HU9501993D0 (en) 1995-08-28
DK0656014T3 (da) 2003-08-11

Similar Documents

Publication Publication Date Title
HU9501993D0 (en) Protein rib, a cell surface protein that confers immunity to strains of the group b streptococcus; process for purification of the protein; reagent kit, and pharmaceutical composition
WO1998018930A3 (en) Streptococcus pneumoniae antigens and vaccines
ES8506348A1 (es) Procedimiento para producir la subunidad b de la toxina del colera
DE69735715D1 (de) Cholin-bindendes Protein, welches als gegen Pneumokokken gerichtetes Vakzin verwendet wird
KR950032279A (ko) 인체의 프로그램된 세포 사멸과 관련 있는 펩티드 및 이를 암호하는 디엔에이(dna)
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
MXPA03009294A (es) Proteinas de superficie de streptococcus pyogenes.
AU1672388A (en) Expression of human proapolipoprotein a-i
NO20006191L (no) Vaksine
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
GR3034766T3 (en) Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections.
WO1998021337A3 (en) C3 BINDING PROTEIN OF $i(STREPTOCOCCUS PNEUMONIAE)
CA2192940A1 (en) Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
NZ500540A (en) Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae
EP0554389A4 (en) Molecular clones of hiv-1 and uses thereof
AU2529095A (en) Vaccine against mycobacterial infections
NO177570B (no) Fremgangsmåte ved fremstilling av peptider med fibronektinbindende egenskaper, mikroorganisme og DNA-sekvens som koder for peptider med fibronektinbindende egenskaper
WO1996008569A3 (en) Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
IT1260153B (it) Individuazione di un frammento di dna codificante l'enzima acido ialuronico sintetasi (has) e della sua sequenza nucleotidica
HUP0104825A2 (hu) Gének, fehérjék és alkalmazásuk
AU1987088A (en) A process for preparing a protein or polypeptide, a dna sequence coding for the polypeptide, a microorganism containing the dna sequence as well as the polypeptide and its use as a pharmaceutical preparation
Schmidt et al. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF
BR9908476A (pt) Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae
AU1440695A (en) P53-based polypeptide fragments, nucleic acid molecules encoding same, and uses thereof